Therapy effect analysis of Urinarykallid on acute cerebral infarction patients with different ages
10.3760/cma.j.issn.1008-6315.2016.04.019
- VernacularTitle:尤瑞克林治疗不同年龄段急性脑梗死患者效果分析
- Author:
Qiangyuan TIAN
;
Peng QI
- Publication Type:Journal Article
- Keywords:
Urinarykallid;
Acute cerebral infarction;
American National Institutes of Health Stroke Scale Score;
Age
- From:
Clinical Medicine of China
2016;32(4):353-355
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of Urinarykallid for different ages patients with acute cerebral infarction cases.Methods Ninety-five cases with acute cerebral infarction were divided into high age group(n=48) and middle age group(n=47).Patients in the two groups were both given the Urinarykallid therapy combined with routine treatment.After 1 courses of treatment(3 weeks),American National Institutes of Health Stroke Scale(NIHSS) were performed before and after the treatment.The adverse reactions occurred in the process of scoring were compared.Results The total effective rate in the high age group was 83.33％,lower than the middle age group(89.36％),but the difference was not statistically significant(P=0.391).The NIHSS scores of patients in the two group after treatment were both significantly reduced compared with that in before treatment (high age grou:(9.81±2.37) vs.(6.79± 0.82),middle age group:(9.75 ± 2.46) vs.(3.04±0.58;P=0.004,P=0.001).Meanwhile,the NIHSS in the middle age group decrease significantly than the high age group(P=0.000).No obvious adverse reactions occurred in both two groups,the treatment was proved with safe and reliable.Conclusion Urinarykallid treatment is showed with better therapy effect on acute cerebral infarction patients with different age,and it is safety with improving patients NIHSS score level.Meanwhile,the better efficacy is showed in patients with lower age.
